A Pilot Study to Evaluate Safety and Efficacy of CigRx™ in Smokers
A Randomized, Double-Blind, Active-Controlled, Crossover, Pilot Study to Evaluate the Safety and Efficacy of CigRx™ Lozenge, a Non-Nicotine Non-Tobacco Dietary Supplement, in Daily Smokers in Temporarily Reducing the Desire to Smoke
  • Phase

    Phase 1
  • Study Type

  • Status

    Completed No Results Posted
  • Intervention/Treatment

    caffeine ...
  • Study Participants

A randomized, double-blind, active-controlled, crossover, pilot study to evaluate the safety and efficacy of CigRx™ Lozenge, a dietary supplement, in daily smokers in temporarily reducing the desire to smoke
Subjects will orally self-administer 2 study products, each in the form of a dissolvable lozenge, and will complete questionnaires on demographics, urges to smoke, and product rating.
Study Started
Apr 30
Primary Completion
Apr 30
Study Completion
Apr 30
Last Update
Oct 30

Dietary Supplement CigRx Lozenge

lozenge made of dietary supplements

Other Tobacco Lozenge

lozenge made of compressed cured tobacco extract

CigRx Lozenge Experimental

CigRx Lozenge

Tobacco Lozenge Active Comparator

Tobacco Lozenge


Inclusion Criteria:

Healthy adult smokers
Smoking for at least 5 years
Smoking at least one (1) pack of cigarettes a day

Exclusion Criteria:

Allergy to lozenge components
No Results Posted